ArticleFrontiers in cardiovascular medicine2026
Contemporary national trends in the management of admissions for pulmonary embolism.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanical Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolism: A Risk-Stratified, Propensity Score-Matched Analysis.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Over the past decade, the inpatient management of pulmonary embolism has undergone a paradigm shift in response to new evidence and the adoption of catheter-directed reperfusion therapies. However, real-world practice patterns remain poorly characterized. Methods: This study used Epic's Cosmos database to analyze admissions for pulmonary embolism in the United States between January 1, 2016, and December 31, 2024. Adult inpatient admissions for pulmonary embolism were identified by International Classification of Diseases, Tenth Revision codes documented in the Results: This study identified a total of 267,094 hospital admissions for pulmonary embolism (mean [SD] age, 63 [17] years; 51.4% female; 71.1% White) between 2016 and 2024. Of these admissions, 5.5% met one or more high-risk criteria, increasing from 4.3% in 2016 to 5.8% in 2024 ( Conclusions: These findings help contextualize the extent to which novel therapies and evolving practice patterns have been integrated into real-world care in the United States. Catheter-directed embolectomy has become the dominant reperfusion strategy for pulmonary embolism, reflecting a major shift in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.